Conferences - Results from #9520

ESMO 2017: Case Studies in mCRPC – Navigating the Increasingly Busy Waters September 9, 2017

ESMO 2017: The Evolving Landscape of Treating Advanced Prostate Cancer September 9, 2017

ESMO 2017: PROREPAIR-B: A prospective cohort study of DNA repair defects in metastatic castration resistant prostate cancer September 9, 2017

ESMO 2017: Adding abiraterone acetate plus prednisolone or docetaxel for patients with high-risk prostate cancer starting long-term androgen deprivation therapy: directly randomized data from STAMPEDE September 9, 2017

ESMO 2017: Lutetium-177 PSMA (LuPSMA) Theranostics Phase II trial: Efficacy, safety and QoL in patients with castrate-resistant prostate cancer treated with LuPSMA September 9, 2017

ESMO 2017: Docetaxel with androgen suppression for high-risk localized prostate cancer patients who relapsed PSA after radical prostatectomy and/or radiotherapy: A randomized phase III trial September 9, 2017

ESMO 2017: Benefits of Abiraterone Acetate Plus Prednisone When Added to Androgen Deprivation Therapy in LATITUDE on Patient Reported Outcomes September 9, 2017

ESMO 2017: Patients with High Risk Prostate Cancer May Benefit “Equally” From Two New Treatments September 9, 2017

ASCO 2017: Identifying and Targeting Genetic Drivers in Rare Genitourinary Cancer Types July 8, 2017

CUA 2017: What’s New in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer? June 27, 2017

CUA 2017: Four vs. 10 Months of Induction Androgen-Deprivation Therapy for Intermittent Therapy (the FIT trial): A Prospective Canadian Urology Research Consortium Randomized Trial June 27, 2017

CUA 2017: A Propensity Score Analysis of Radical Cystectomy vs. Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic June 27, 2017

CUA 2017: Safety of Minimizing Intensity of Followup on Active Surveillance for Clinical Stage I Testicular Germ Cell Tumors June 27, 2017

CUA 2017: Long-Term Incidence of Venous Thromboembolic Events Following cystectomy: A Population-Based Analysis June 27, 2017

CUA 2017: Radical Cystectomy After Prior Partial Cystectomy for Urothelial Carcinoma: Perioperative and Oncological Outcomes June 27, 2017

CUA 2017: Creation of a Prediction Tool for Renal Function After Partial and Radical Nephrectomy: Personalizing Decision-Making for Renal Cancer Surgery June 26, 2017

CUA 2017: Correlation of Transperineal Prostate Biopsy-Detected Cancer with Magnetic Resonance Imaging-Predicted Lesion in Patients with Previous Negative Transrectal Ultrasound-Guided Prostate Biopsies June 26, 2017

CUA 2017: Is Tumor Location in Upper Tract Urothelial Carcinoma an Important Prognostic Factor? June 26, 2017

CUA 2017: Cystic Renal Masses: Is the Bosniak Classification System an Adequate Predictor of Survival? June 26, 2017

CUA 2017: The Prevalence and Biopsychosocial Predictors of Suicidality in Men with Prostate Cancer June 26, 2017

Page 477 of 619